Trident Texofab Navigates Q3FY26 with Strategic Shift and Profit Growth

Trident Texofab Limited, a prominent player in the textile sector, recently unveiled its earnings presentation for the third quarter of fiscal year 2026 (Q3FY26). The company reported a revenue from operations of 2,574.09 Lakhs for the quarter. While this represents a 19% year-on-year decline from 3,168.94 Lakhs in Q3FY25, the underlying narrative points to a successful strategic transformation. The company's 'Shifting Gears' strategy, initiated in FY19, has seen it transition from a predominantly trading-focused entity to a semi-composite textile manufacturer. This pivot is evident in the revenue mix, with manufacturing operations contributing a significant 61.8% to the total revenue in Q3FY26, while trading accounted for 38.2%.

Despite the top-line contraction, Trident Texofab demonstrated robust profitability growth. The Profit After Taxes (PAT) for Q3FY26 surged by an impressive 90% year-on-year, reaching 57.01 Lakhs compared to 29.98 Lakhs in Q3FY25. This strong performance was not limited to the quarter, as the PAT for the nine months ended December 31, 2025 (9MFY26), stood at 361.65 Lakhs, marking a 65% growth year-on-year. This indicates that the strategic shift towards manufacturing is yielding positive results on the profitability front, even as the company navigates a challenging revenue environment. However, the EBITDA (Excluding Other Income and Exceptional Items) for Q3FY26 saw a 29% decline year-on-year to 164.50 Lakhs, leading to a 94 basis points contraction in EBITDA margins, which settled at 6.39%.

Strategic Investments and Capacity Augmentation

Trident Texofab's journey of transformation is underpinned by strategic capital expenditures. The company initiated its 1st Phase of CAPEX in September 2018, investing in a Waterjet Unit, a Value-added Contract Manufacturing facility for Embroidery, and a Digital Printing Unit. These investments established significant capacities, including approximately 22 Lakh Meters per Month for the Waterjet Unit, 37 Lakh Stitches per Day for the Embroidery Unit, and 7,200 Meters per Day for the Digital Printing Unit.

Further solidifying its manufacturing prowess, the company completed its 2nd Phase of CAPEX by commissioning a Rapier Unit. A crucial 3rd Phase of CAPEX was executed in June 2021 at its Hojiwala Facility in Sachin. This expansion significantly augmented the Waterjet Unit's capacity from 8-9 lakh meters per month to an impressive 20-22 lakh meters per month. These capacity enhancements are central to the company's strategy to drive growth and improve profitability margins by focusing on high-value manufacturing operations.

Product Portfolio and Operational Focus

Trident Texofab boasts an expansive product portfolio across both its manufacturing and trading verticals. The manufacturing vertical produces finished products such as embroidered fabrics, digital printed fabrics, bed sheets, technical textiles, suiting, and various polyester and poly-blend fabrics. It also deals in semi-finished products like grey fabrics, contract manufacturing in digital printing, and value-added products in embroidery. The trading vertical includes home furnishing products like bed sheets, curtains, and cushion covers, as well as clothing articles such as scarfs, pareos, suiting, shirting, and technical textile fabrics.

Management commentary emphasizes a continued focus on manufacturing operations as the core strength of the company. This strategic prioritization is expected to drive growth and enhance profitability margins. Following recent capital infusion, the company believes it is well-positioned to capitalize on future growth opportunities. The trading operations are expected to maintain a similar run rate, with no further significant investments planned for this vertical, reinforcing the manufacturing-centric approach.

Outlook and Investor Confidence

Trident Texofab's Q3FY26 results highlight a company in transition, successfully re-aligning its business model towards manufacturing. While revenue faced headwinds, the significant growth in PAT underscores the effectiveness of its strategic pivot and capital allocation towards higher-margin activities. The disciplined execution of CAPEX projects has built a robust manufacturing base, providing a strong foundation for future growth. The management's clear articulation of prioritizing manufacturing and leveraging recent capital infusion instills confidence in its ability to navigate market dynamics and unlock long-term value for stakeholders.